Ipsen (CHIX:IPNP) Net Change in Cash : €55 Mil (TTM As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Ipsen Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Ipsen's Net Change in Cash for the six months ended in Dec. 2023 was €107 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was €55 Mil.

Ipsen Net Change in Cash Historical Data

The historical data trend for Ipsen's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen Net Change in Cash Chart

Ipsen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

28.10

300.60

145.30

354.50

-659.70

Ipsen Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Change in Cash	Get a 7-Day Free Trial															226.60	127.90	-766.90	107.20	-52.00

Ipsen Net Change in Cash Calculation

Ipsen's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	865.9	+	-1072.2	+	-458.4	+	5
	=	-660

Ipsen's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 436.5 + -86.2 + -248.3 + 5.2

= 107

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ipsen Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Ipsen's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipsen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (CHIX:IPNp) » Definitions » Net Change in Cash

Comparable Companies

XPAR:VETO XPAR:BOI XPAR:EAPI XPAR:AB XPAR:ALRPD XPAR:MLCOT ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS HKSE:03692 SZSE:000538 NBIX NSE:TORNTPHARM

Traded in Other Exchanges

IPSEY:USA IPSEF:USA 0MH6:UK IPN:France I7G:Germany

Address

65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100

Website

https://www.ipsen.com

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.

Ipsen Headlines

No Headlines